SCHEDULE: American Century Reports 4.2% Stake in Blue Bird

American Century Investment Management, Inc., along with its parent companies, reported a 4.2% beneficial ownership stake in Blue Bird Corporation's common stock.

Summary

• American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research collectively reported beneficial ownership of 1,334,710 shares of Blue Bird Corporation's Common Stock.
• This represents 4.2% of the class of securities.
• The reporting persons hold sole voting power over 1,308,937 shares and sole dispositive power over 1,334,710 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to previously reported beneficial ownership.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment towards the company or its performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding Blue Bird Corporation's future performance or operations.

Industry Context

This filing is a routine disclosure of an institutional investor's passive ownership stake, common in the financial industry for transparency regarding significant holdings in publicly traded companies.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holding, confirming a passive investment approach by American Century.

Key Dates

Keywords

Blue Bird Corporation, American Century Investment Management, Stowers Institute for Medical Research, Beneficial Ownership, Schedule 13G, Common Stock, Institutional Investor, Equity Stake